MoneyMatters Blog

    
AlphaProfit MoneyMatters Investing Blog RSS Feed

"In the investing blog, I seek to help you take sound investment decisions free from emotion by sharing my objective insights on markets, sectors, and companies."
Sam Subramanian PhD, MBA, Editor, AlphaProfit MoneyMatters

Biotech Stocks and ETFs: Should You Board the Biotech Bandwagon Now?

July has been a good month for biotech investors. Share prices in the biotech sector as measured by the NYSE Biotechnology Index are up 24% compared to the 6.6% gain for the S&P 500. Earlier in the month, Amgen (AMGN) reported better-than-expected results from a trial of its experimental bone-protecting drug denosumab in patients with advanced breast cancer.… Read More »

Sector Investing: Should You Be in the Tech Sector Now?

The week past was a noteworthy one for technology investors. Share prices in this sector zoomed higher by 9.4%. After Tuesday’s market close, Intel’s (INTC) second quarter earnings announcement injected life back into the stock market and triggered a bull stampede in many tech names. The Good Intel reported its strongest growth from the first quarter to the… Read More »

New ETF Recommendations


New ETF Recommendations

The AlphaProfit ETF style rotation model portfolio will be reconstituted with new recommendations on Wednesday, November 19. Learn more about AlphaProfit's Free and Premium Service investment newsletters.